Biotech

All Articles

Navigator brings up $100M to create brand-new autoimmune pipe

.Navigator Medicines has furnished itself with $100 million in series A funds as the younger biotech...

Duality looks for cash money for ADC tests as IPO surge spreads to Asia

.China's Duality Biotherapeutics has actually submitted (PDF) documents for a Hong Kong IPO, seeking...

YolTech markets China rights to gene modifying treatment for $29M

.4 months after Mandarin genetics modifying business YolTech Therapies took its cholesterol levels d...

Addex stock rises after Indivior provides to $300M for compound

.Indivior is picking up a tiny molecule allosteric modulator designed to manage element use disorder...

Molecular Allies modifies AML trial over 'suboptimal exposure'

.Molecular Partners has determined "suboptimal exposure" to its tetra-specific T-cell engager as the...

Despite blended market, an equity capital resurgence can be coming in Europe: PitchBook

.While the biotech financial investment performance in Europe has actually slowed somewhat following...

8 months after a $213M fundraise, gene editor Tome produces cuts

.After increasing $213 thousand in 2023-- among the year's largest exclusive biotech rounds-- Volume...

BioMarin creates exec group with biotech veterinarians-- Chutes &amp Ladders

.Welcome to recently's Chutes &amp Ladders, our roundup of considerable management hirings, firings ...

Biopharma Q2 VC attacked highest degree given that '22, while M&ampA reduced

.Equity capital financing in to biopharma rose to $9.2 billion throughout 215 sell the 2nd fourth of...

Bicara, Zenas seek IPOs to press late-phase possessions toward market

.Bicara Rehabs as well as Zenas Biopharma have provided new incentive to the IPO market along with f...